Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Self-reporting of hearing loss...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis

Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis

Bibliographic Details
Main Authors: Claudia Cristina Jardim Duarte, Tania Salgado de Sousa Torraca, Débora de Oliveira Bezerra, Renata de Barcelos Oliveira, Nayany Kerollyany Sousa Leite, Raquel de Vasconcellos Carvalhaes de Oliveira, Maria Helena Araújo-Melo, Maria Inês Fernandes Pimentel, Ananda Dutra da Costa, Érica de Camargo Ferreira Vasconcellos, Marcelo Rosandiski Lyra, Ester Cleisla dos Anjos Soares, Lúcia Regina do Nascimento Brahim Paes, Mariza Mattos Salgueiro, Armando de Oliveira Schubach, Cláudia Maria Valete
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866496/?tool=EBI
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10866496/?tool=EBI

Similar Items

  • FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE
    by: Cláudia Maria Valete-Rosalino, et al.
    Published: (2014-09-01)
  • Alterations in Evoked Otoacoustic Emissions by the Use of Meglumine Antimoniate in American Tegumentary Leishmaniasis Patients.
    by: Débora Cristina de Oliveira Bezerra, et al.
    Published: (2017-01-01)
  • Favorable responses to treatment with 5 mg Sbv/kg/day meglumine antimoniate in patients with American tegumentary leishmaniasis acquired in different Brazilian regions
    by: Jamyra Iglesias Cataldo, et al.
  • Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
    by: Maria Cristina de Oliveira Duque, et al.
  • RESOLUTION OF CUTANEOUS LEISHMANIASIS AFTER ACUTE ECZEMA DUE TO INTRALESIONAL MEGLUMINE ANTIMONIATE
    by: Erica de Camargo Ferreira e Vasconcellos, et al.
    Published: (2014-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs